• Tidak ada hasil yang ditemukan

Supplementary Figure 1:

N/A
N/A
Protected

Academic year: 2024

Membagikan "Supplementary Figure 1:"

Copied!
3
0
0

Teks penuh

(1)

Supplementary Figure 1: Hazards ratios (HR) for all-cause mortality in our entire ABPM-referred cohort (treated and untreated patients) according to body mass index (BMI). The predicted HR and 95% confidence intervals were generated using spline regression with adjustment for age, sex and 24░h systolic blood pressure

(R/Bioconductor packages ‘survival’ and ‘pspline’).

Supplementary Figure 2: To capture the U-like association between body mass index (BMI) and all-cause mortality, with minimum ~25░kg/m2, we plotted hazards ratios according to deciles of (BMI-25)2 (corresponding BMI values are depicted below the x- axis for clarity). Hazards ratios were derived from Cox proportional hazards models that also included age, gender, treatment for diabetes (model 1) and in addition non-

transformed BMI (model 2). Overall model fit was stronger with model 2 (2=747.1) compared with model 1 (2=699.6), P░=░0.008 for the change in 2. We thus introduced both BMI and squared BMI to subsequent outcome models.

Supplementary Figure 3: Subgroup analysis of mortality according to awake ambulatory blood pressure. A) Subjects with awake ambulatory BP░<░135/85 mmHg: SSL/SSI – 28 events in 614 patients; SSH – 7 events in 107 patients; Log-Rank P░=░0.406. B)

Subjects with awake ambulatory hypertension: SSL/SSI – 78 events in 1183 patients;

SSH – 20 events in 160 patients; Log-Rank P░=░0.018.

(2)

20 25 30 35

0.00.51.01.52.0

BMI, kg/m^2

Hazard Ratio

Supplementary figures 1

R² = 0.7815 R² = 0.9158 0

0.5 1 1.5 2 2.5

25 26 28 30 32 34 36

Hazards Ratio

BMI, kg/m^2 model 1 model 2

2

(BMI-25)^2, kg^2/m^4

0 1 9 25 49 81 121

(3)

normal awake blood pressure

high awake blood pressure A

B

Supplementary Figure 3

Referensi

Dokumen terkait

Supplementary Figure 2: Number of admissions and incidence rate ratios IRRs for person-level predictors of any preventable hospitalisation, in multilevel Poisson models simultaneously

LIST OF ABBREVIATIONS ACTH Adrenocortiotropic hormone BMI Body Mass Index kg/m2 CRH Corticotropin-releasing hormone GAD Generalized Anxiety Disorder GAS Generalized Adaptation

Supplementary Figure 1: CONSORT Flow Chart 1: Not available; assessed at follow-up Assessed at End of Study: 20 Assessed at End of Study: 22 Assessed at Follow-Up: 21 Assessed at

Supplementary methods Definitions: - body mass index BMI; body weight [kg]/height [m]2 - concurrent nephrotoxic drugs: ganciclovir, NSAIDs, and sulfamethoxazole/trimethoprim -

Start time of treatment Before laparoscopic sleeve gastrectomy 32.3 drug free 86.2 84.04 1.0 Before colon cancer surgery BMI kg/m2 HbA1c [NGSP] % %VC FEV1.0%-G AHI BMI, body mass

Donor Details Age 71 BMI kg/m2 32 Donor Liver Weight kg 1.8kg Donor Type DBD Cause of Death Intracranial Hemorrhage Donor Risk Index 2 2.0 UK Donor Liver Index 1.15 Cold

Supplemetary Table 3: Changes over time of left ventricular mass LVM indexed for body surface area LVMi and LVM indexed for height2.7 in post‐ 1 dilution online hemodiafiltration and

Body size Body Mass Index – BMI SD and body composition Fat Mass Index – FMI; Fat Free Mass Index – FFMI; Lean Mass Index ‐LMi; Bone Mineral Content Index –BMCI, as assessed using BIA